Metropolitan Life Insurance CO Medpace Holdings, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

55 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $32,770 - $45,029	-188 Reduced 12.06%	1,371 $257,000
Q4 2022 Jun 14, 2023	BUY	$153.06 - $226.57 $28,775 - $42,595	188 Added 13.71%	1,559 $331 Million
Q4 2022 Mar 30, 2023	BUY	$153.06 - $226.57 $5,204 - $7,703	34 Added 2.23%	1,559 $331,000
Q4 2022 Feb 15, 2023	BUY	$153.06 - $226.57 $5,204 - $7,703	34 Added 2.23%	1,559 $331,000
Q3 2022 Jun 14, 2023	BUY	$145.13 - $182.49 $22,350 - $28,103	154 Added 11.23%	1,525 $240 Million
Q3 2022 Mar 30, 2023	SELL	$145.13 - $182.49 $19,737 - $24,818	-136 Reduced 8.19%	1,525 $239,000
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $19,737 - $24,818	-136 Reduced 8.19%	1,525 $240,000
Q2 2022 Jun 20, 2023	BUY	$130.2 - $168.03 $37,758 - $48,728	290 Added 21.15%	1,661 $248,000
Q2 2022 Mar 30, 2023	SELL	$130.2 - $168.03 $20,701 - $26,716	-159 Reduced 8.74%	1,661 $248,000
Q2 2022 Aug 11, 2022	SELL	$130.2 - $168.03 $20,701 - $26,716	-159 Reduced 8.74%	1,661 $249,000
Q1 2022 Jun 20, 2023	BUY	$138.87 - $214.31 $62,352 - $96,225	449 Added 32.75%	1,820 $297,000
Q1 2022 Mar 30, 2023	SELL	$138.87 - $214.31 $1.41 Million - $2.17 Million	-10,126 Reduced 84.76%	1,820 $297,000
Q1 2022 May 12, 2022	SELL	$138.87 - $214.31 $1.41 Million - $2.17 Million	-10,126 Reduced 84.76%	1,820 $298,000
Q4 2021 Jun 21, 2023	BUY	$182.74 - $227.9 $1.93 Million - $2.41 Million	10,575 Added 771.33%	11,946 $2.6 Million
Q4 2021 Mar 30, 2023	SELL	$182.74 - $227.9 $55,735 - $69,509	-305 Reduced 2.49%	11,946 $2.6 Million
Q4 2021 Feb 15, 2022	SELL	$182.74 - $227.9 $55,735 - $69,509	-305 Reduced 2.49%	11,946 $2.6 Million
Q3 2021 Jun 21, 2023	BUY	$170.18 - $198.21 $1.85 Million - $2.16 Million	10,880 Added 793.58%	12,251 $2.32 Million
Q3 2021 Mar 30, 2023	SELL	$170.18 - $198.21 $74,368 - $86,617	-437 Reduced 3.44%	12,251 $2.32 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $74,368 - $86,617	-437 Reduced 3.44%	12,251 $2.32 Million
Q2 2021 Jun 21, 2023	BUY	$158.62 - $194.3 $1.8 Million - $2.2 Million	11,317 Added 825.46%	12,688 $2.24 Million
Q2 2021 Mar 30, 2023	BUY	$158.62 - $194.3 $80,896 - $99,093	510 Added 4.19%	12,688 $2.24 Million
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $2.01 Million - $2.46 Million	12,676 Added 105633.33%	12,688 $2.24 Million
Q1 2021 Jun 26, 2023	BUY	$132.02 - $168.26 $1.43 Million - $1.82 Million	10,807 Added 788.26%	12,178 $2 Billion
Q1 2021 Mar 30, 2023	SELL	$132.02 - $168.26 $10,033 - $12,787	-76 Reduced 0.62%	12,178 $2 Million
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $1.62 Million - $2.06 Million	-12,242 Reduced 99.9%	12 $2 Million
Q4 2020 Jun 22, 2023	BUY	$109.38 - $149.19 $1.19 Million - $1.62 Million	10,883 Added 793.8%	12,254 $1.71 Million
Q4 2020 Mar 30, 2023	SELL	$109.38 - $149.19 $7,547 - $10,294	-69 Reduced 0.56%	12,254 $1.71 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $7,547 - $10,294	-69 Reduced 0.56%	12,254 $1.71 Million
Q3 2020 Jun 26, 2023	BUY	$92.95 - $130.61 $1.02 Million - $1.43 Million	10,952 Added 798.83%	12,323 $1.38 Million
Q3 2020 Mar 30, 2023	BUY	$92.95 - $130.61 $368,360 - $517,607	3,963 Added 47.4%	12,323 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$92.95 - $130.61 $368,360 - $517,607	3,963 Added 47.4%	12,323 $1.38 Million
Q2 2020 Jun 26, 2023	BUY	$68.08 - $95.68 $475,811 - $668,707	6,989 Added 509.77%	8,360 $777,000
Q2 2020 Mar 30, 2023	SELL	$68.08 - $95.68 $136 - $191	-2 Reduced 0.02%	8,360 $777,000
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $136 - $191	-2 Reduced 0.02%	8,360 $778,000
Q1 2020 Jul 12, 2023	BUY	$61.71 - $101.95 $440,115 - $727,107	7,132 Added 520.2%	8,503 $623,000
Q1 2020 Mar 30, 2023	SELL	$61.71 - $101.95 $33,014 - $54,543	-535 Reduced 6.01%	8,362 $613,000
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $33,014 - $54,543	-535 Reduced 6.01%	8,362 $614,000
Q4 2019 Jul 12, 2023	BUY	$70.08 - $84.64 $527,422 - $637,000	7,526 Added 548.94%	8,897 $747,000
Q4 2019 Mar 30, 2023	SELL	$70.08 - $84.64 $12,404 - $14,981	-177 Reduced 1.95%	8,897 $747,000
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $12,404 - $14,981	-177 Reduced 1.95%	8,897 $748,000
Q3 2019 Jul 12, 2023	BUY	$62.38 - $85.89 $480,513 - $661,610	7,703 Added 561.85%	9,074 $762,000
Q3 2019 Mar 30, 2023	BUY	$62.38 - $85.89 $121,204 - $166,884	1,943 Added 27.25%	9,074 $762,000
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $121,204 - $166,884	1,943 Added 27.25%	9,074 $763,000
Q2 2019 Jul 12, 2023	BUY	$53.64 - $65.42 $331,334 - $404,099	6,177 Added 450.55%	7,548 $493,000
Q1 2019 Jul 13, 2023	BUY	$49.38 - $70.58 $284,428 - $406,540	5,760 Added 420.13%	7,131 $420,000
Q1 2019 Mar 30, 2023	BUY	$49.38 - $70.58 $275,145 - $393,271	5,572 Added 357.41%	7,131 $420,000
Q1 2019 May 16, 2019	SELL	$49.38 - $70.58 $140,979 - $201,505	-2,855 Reduced 28.59%	7,131 $420,000
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $140,979 - $201,505	2,855 Added 40.04%	9,986 $88,000
Q4 2018 Jul 13, 2023	BUY	$46.97 - $63.98 $270,547 - $368,524	5,760 Added 420.13%	7,131 $377,000
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $261,575 - $356,304	5,569 Added 356.53%	7,131 $377,000
Q3 2018 Jul 13, 2023	BUY	$43.25 - $63.74 $249,120 - $367,142	5,760 Added 420.13%	7,131 $427 Million
Q3 2018 Nov 14, 2018	SELL	$43.25 - $63.74 $111,671 - $164,576	-2,582 Reduced 62.31%	1,562 $94,000
Q2 2018 Aug 15, 2018	BUY	$34.03 - $45.46 $51,283 - $68,508	1,507 Added 57.15%	4,144 $0
Q4 2017 Feb 15, 2018	SELL	$32.46 - $38.31 $91,861 - $108,417	-2,830 Reduced 51.77%	2,637 $96,000
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $149,959 - $181,012	5,467	5,467 $174,000

Others Institutions Holding MEDP

# of Institutions

653

Shares Held

25.6M

Call Options Held

38.7K

Put Options Held

79.5K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account